Your browser doesn't support javascript.
loading
Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial.
Matikas, Alexios; Johansson, Hemming; Grybäck, Per; Bjöhle, Judith; Acs, Balazs; Boyaci, Ceren; Lekberg, Tobias; Fredholm, Hanna; Elinder, Ellinor; Margolin, Sara; Isaksson-Friman, Erika; Bosch, Ana; Lindman, Henrik; Adra, Jamila; Andersson, Anne; Agartz, Susanne; Hellström, Mats; Zerdes, Ioannis; Hartman, Johan; Bergh, Jonas; Hatschek, Thomas; Foukakis, Theodoros.
Affiliation
  • Matikas A; Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.
  • Johansson H; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Grybäck P; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Bjöhle J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Acs B; Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.
  • Boyaci C; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Lekberg T; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
  • Fredholm H; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Elinder E; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
  • Margolin S; Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.
  • Isaksson-Friman E; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Bosch A; Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.
  • Lindman H; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Adra J; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
  • Andersson A; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
  • Agartz S; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
  • Hellström M; Breast Center, St Göran Hospital, Stockholm, Sweden.
  • Zerdes I; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
  • Hartman J; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.
  • Bergh J; Department of Oncology, Sahlgrenska University Hospital, Göteborg, Sweden.
  • Hatschek T; Department of Radiation Sciences, Oncology Unit, Umeå University Hospital, Umeå, Sweden.
  • Foukakis T; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden.
Clin Cancer Res ; 29(3): 532-540, 2023 02 01.
Article in En | MEDLINE | ID: mdl-36449695
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Sweden
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Sweden